NASDAQ CGEM opened at $8.49 on Monday. Cullinan Therapeutics has a 1 year low of $8.29 and a 1 year high of $30.19. The stock has a market capitalization of $494.36 million, a PE ratio of -2.99 ...
Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Cullinan Management (CGEM – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback